drugset / Trial / NCT00180076

Budesonide for Maintenance Treatment of Collagenous Colitis

NCT00180076 ↗

Phase 3 Completed 75 enrolled Technical University Dresden AstraZeneca · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis.

Timeline

Start
2004-07
Primary completion
2007-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule — Oral

Indications